BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31325493)

  • 1. Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation.
    Zaffiri L; Shah RJ; Stearman RS; Rothhaar K; Emtiazjoo AM; Yoshimoto M; Fisher AJ; Mickler EA; Gartenhaus MD; Cohort LTOG; Diamond JM; Geraci MW; Christie JD; Wilkes DS
    Transpl Immunol; 2019 Oct; 56():101224. PubMed ID: 31325493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.
    Iwata T; Philipovskiy A; Fisher AJ; Presson RG; Chiyo M; Lee J; Mickler E; Smith GN; Petrache I; Brand DB; Burlingham WJ; Gopalakrishnan B; Greenspan DS; Christie JD; Wilkes DS
    J Immunol; 2008 Oct; 181(8):5738-47. PubMed ID: 18832733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.
    Bobadilla JL; Love RB; Jankowska-Gan E; Xu Q; Haynes LD; Braun RK; Hayney MS; Munoz del Rio A; Meyer K; Greenspan DS; Torrealba J; Heidler KM; Cummings OW; Iwata T; Brand D; Presson R; Burlingham WJ; Wilkes DS
    Am J Respir Crit Care Med; 2008 Mar; 177(6):660-8. PubMed ID: 18174545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.
    Burlingham WJ; Love RB; Jankowska-Gan E; Haynes LD; Xu Q; Bobadilla JL; Meyer KC; Hayney MS; Braun RK; Greenspan DS; Gopalakrishnan B; Cai J; Brand DD; Yoshida S; Cummings OW; Wilkes DS
    J Clin Invest; 2007 Nov; 117(11):3498-506. PubMed ID: 17965778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.
    Yoshida S; Haque A; Mizobuchi T; Iwata T; Chiyo M; Webb TJ; Baldridge LA; Heidler KM; Cummings OW; Fujisawa T; Blum JS; Brand DD; Wilkes DS
    Am J Transplant; 2006 Apr; 6(4):724-35. PubMed ID: 16539629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection.
    Braun RK; Molitor-Dart M; Wigfield C; Xiang Z; Fain SB; Jankowska-Gan E; Seroogy CM; Burlingham WJ; Wilkes DS; Brand DD; Torrealba J; Love RB
    Transplantation; 2009 Dec; 88(12):1341-8. PubMed ID: 20029330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.
    Tiriveedhi V; Angaswamy N; Brand D; Weber J; Gelman AG; Hachem R; Trulock EP; Meyers B; Patterson G; Mohanakumar T
    Clin Exp Immunol; 2012 Jan; 167(1):158-68. PubMed ID: 22132895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
    Yamada Y; Sekine Y; Yoshida S; Yasufuku K; Petrache I; Benson HL; Brand DD; Yoshino I; Wilkes DS
    J Immunol; 2009 Jul; 183(1):237-45. PubMed ID: 19542435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation.
    Bharat A; Chiu S; Zheng Z; Sun H; Yeldandi A; DeCamp MM; Perlman H; Budinger GR; Mohanakumar T
    Am J Respir Cell Mol Biol; 2016 Oct; 55(4):532-541. PubMed ID: 27144500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.
    Haque MA; Mizobuchi T; Yasufuku K; Fujisawa T; Brutkiewicz RR; Zheng Y; Woods K; Smith GN; Cummings OW; Heidler KM; Blum JS; Wilkes DS
    J Immunol; 2002 Aug; 169(3):1542-9. PubMed ID: 12133982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2010 Oct; 90(4):1094-101. PubMed ID: 20868794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.
    Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.
    Tiriveedhi V; Gautam B; Sarma NJ; Askar M; Budev M; Aloush A; Hachem R; Trulock E; Myers B; Patterson AG; Mohanakumar T
    J Heart Lung Transplant; 2013 Aug; 32(8):807-14. PubMed ID: 23856218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression.
    Iwata T; Chiyo M; Yoshida S; Smith GN; Mickler EA; Presson R; Fisher AJ; Brand DD; Cummings OW; Wilkes DS
    Transplantation; 2008 Feb; 85(3):417-26. PubMed ID: 18322435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type V collagen modulates alloantigen-induced pathology and immunology in the lung.
    Mares DC; Heidler KM; Smith GN; Cummings OW; Harris ER; Foresman B; Wilkes DS
    Am J Respir Cell Mol Biol; 2000 Jul; 23(1):62-70. PubMed ID: 10873154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling.
    Bharat A; Fields RC; Trulock EP; Patterson GA; Mohanakumar T
    J Immunol; 2006 Oct; 177(8):5631-8. PubMed ID: 17015751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection.
    Sumpter TL; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1129-39. PubMed ID: 15136293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
    Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
    PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis.
    Vittal R; Fan L; Greenspan DS; Mickler EA; Gopalakrishnan B; Gu H; Benson HL; Zhang C; Burlingham W; Cummings OW; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(6):L401-14. PubMed ID: 23262228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung.
    Chiyo M; Iwata T; Webb TJ; Vasko MR; Thompson EL; Heidler KM; Cummings OW; Yoshida S; Fujisawa T; Brand DD; Wilkes DS
    Am J Transplant; 2008 Mar; 8(3):537-46. PubMed ID: 18294150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.